Gennex Laboratories Limited (BOM:531739)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Bulk Drugs, Biotech Products and Intermediates	1.73B	1.38B	867.14M	656.03M	612.14M
Total	1.73B	1.38B	867.14M	656.03M	612.14M

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Algeria	681.00K	5.11M	-	-
Bangladesh	1.52M	-	3.16M	5.46M
Colombia	49.27M	932.00K	4.62M	9.48M
Czech Republic	457.00K	211.00K	-	-
Egypt	52.01M	20.30M	57.33M	73.22M
El Salvador	25.16M	7.70M	9.21M	-
Guatemala	9.68M	15.63M	11.75M	15.63M
Mexico	28.51M	-	503.00K	-
Peru	27.89M	14.00M	19.00M	18.78M
Russia	-	4.30M	456.00K	-
Turkey	162.00K	179.00K	484.00K	347.00K
Thailand	2.50M	1.85M	-	-
UAE	8.65M	1.02M	-	-
Vietnam	109.25M	95.67M	88.98M	44.41M
India	621.53M	442.71M	380.28M	276.52M
Brazil	1.25M	224.00K	-	-
Bolivia	314.00K	-	-	-
China	-	2.25M	-	-
Germany	2.83M	12.62M	8.07M	13.00M
Iran	-	187.00K	6.89M	6.05M
Saudi Arabia	-	5.92M	3.61M	2.60M
Spain	4.13M	37.18M	41.95M	109.89M
Belgium	-	-	165.00K	682.00K
Cuba	-	-	12.69M	-
Swizerland	-	-	690.00K	32.02M
Uruguay	-	-	1.15M	536.00K
Canada	-	-	-	726.00K
Kenya	-	-	-	203.00K
Netherland	-	-	-	326.00K
Singapore	-	-	-	2.26M
Total	945.78M	667.99M	650.98M	612.14M

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 27, 2026

Data Sources Report a data error